ID: ALA4075750
Max Phase: Preclinical
Molecular Formula: C11H16N4O
Molecular Weight: 220.28
Molecule Type: Small molecule
Associated Items:
ID: ALA4075750
Max Phase: Preclinical
Molecular Formula: C11H16N4O
Molecular Weight: 220.28
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1nc(N2CCC2)nc(N2CCC2)c1O
Standard InChI: InChI=1S/C11H16N4O/c1-8-9(16)10(14-4-2-5-14)13-11(12-8)15-6-3-7-15/h16H,2-7H2,1H3
Standard InChI Key: LJWAJPFBVHOEHO-UHFFFAOYSA-N
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 220.28 | Molecular Weight (Monoisotopic): 220.1324 | AlogP: 0.91 | #Rotatable Bonds: 2 |
Polar Surface Area: 52.49 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.72 | CX Basic pKa: 7.65 | CX LogP: 1.14 | CX LogD: 0.71 |
Aromatic Rings: 1 | Heavy Atoms: 16 | QED Weighted: 0.80 | Np Likeness Score: -1.15 |
1. Chevalier A, Khdour OM, Schmierer M, Bandyopadhyay I, Hecht SM.. (2017) Influence of substituent heteroatoms on the cytoprotective properties of pyrimidinol antioxidants., 25 (5): [PMID:28189395] [10.1016/j.bmc.2017.01.030] |
Source(1):